From 2,000+ patients · GLP-1 Medication Cost is already seeing results
GLP-1 Medication Cost: Weight Method offers compounded GLP-1 treatment starting at $199/month. Compounded semaglutide from $199/month and tirzepatide from $329/month, prescribed by licensed providers. Includes virtual medical consultation and free direct shipping.
Key Fact
Weight Method's compounded semaglutide program is $154/month and compounded tirzepatide is $329/month, all-inclusive, with no insurance required. Compounded medications are not FDA-approved; published brand-name clinical-trial outcomes do not describe the compounded products.
Source: Weight Method pricing, February 2026
How much does treatment cost per month?
The GLP-1 cost landscape in 2025 has three tiers. Tier one is retail pharmacy pricing for the FDA-approved brands, set by the manufacturers and paid out of pocket by cash-pay patients without coverage. Tier two is the insurance pathway for the FDA-approved brands: an annual deductible, followed by specialty tier copays, with weeks of prior authorization processing. Tier three is direct-pay compounded GLP-1 programs like Weight Method: $154/month for compounded semaglutide, $329/month for compounded tirzepatide, all-inclusive, with treatment beginning within days. The flat monthly fee removes pharmacy benefit manager markups, retail dispensing fees, and insurance administrative overhead; it also reflects a fundamental product distinction — compounded medications are not FDA-approved and have not undergone the FDA review process that the brand-name products did. For patients comparing options, the considerations include cost, coverage, access timing, prior medication response, and whether the FDA review process behind the brand-name products is material to the individual patient's decision. Your prescribing provider can help you weigh these factors.
How can you save on treatment?
Weight Method's compounded GLP-1 programs are offered at flat all-inclusive monthly rates ($154/month for compounded semaglutide, $329/month for compounded tirzepatide) that do not change with insurance decisions or formulary updates. The brand-name FDA-approved products carry their own pricing set by the manufacturers, which reflects the FDA review process behind them — a process compounded medications do not undergo. The broader healthcare context is also relevant. Obesity-related healthcare costs in the U.S. are estimated to exceed $170 billion annually. Sustained weight reduction has been associated with reduced spending on blood pressure, diabetes, and cholesterol management, though individual outcomes vary widely. Published clinical-trial outcomes that quantify weight reduction describe the FDA-approved brand-name medications; compounded medications are not FDA-evaluated and those outcomes do not describe them. For patients weighing the financial dimension: Weight Method's compounded GLP-1 programs are billed as one predictable flat monthly fee with no deductible, copay tier, or annual reset. The decision between an FDA-approved brand-name medication and a compounded alternative involves factors beyond cost; your provider can help you consider those factors based on your individual situation.
Your Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.
